IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor

Journal of Immunology

Volumn 170, Issue 7, 2003, Pages 3461-3467

  Matsuzawa, Shigeyuki ^a   Sakashita, Kazuo ^a   Kinoshita, Tatsuya ^a   Ito, Susumu ^a   Yamashita, Tetsuji ^b   Koike, Kenichi ^a,c  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; INTERLEUKIN 9; STEM CELL FACTOR;

ADOLESCENT; ARTICLE; ASTHMA; CASE REPORT; CELL MATURATION; CHILD; GROWTH REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MAST CELL; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

EID: 0037378715     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.7.3461     Document Type: Article

References (29)

1. Irani, A. M., G. Nilsson, U. Miettinen, S. S. Craig, L. K. Ashman, T. Ishizaka, K. M. Zsebo, and L. B. Schwartz. 1992. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009.
2. Valent, P., E. Spanblochl, W. R. Sperr, C. Sillaber, K. M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80:2237.
3. Mitsui, H., T. Furitsu, A. M. Dvorak. A. M. Irani, L. B. Schwartz, N. Inagaki, M. Takei, K. Ishizaka, K. M. Zsebo, S. Gillis, and T. Ishizaka. 1993. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc. Natl. Acad. Sci. USA 90:735.
4. Sawai, N., K. Koike, H. H. Mwamtemi, T. Kinoshita, Y. Kurokawa, K. Sakashita, T. Higuchi, K. Takeuchi, M. Shiohara, T. Kamijo, et al. 1999. Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors. Blood 93:3703.
5. + cord blood cells. Blood 94:496.
6. Kinoshita, T., K. Koike, H. H. Mwamtemi, S. Ito. S. Ishida, Y. Nakazawa, Y. Kurokawa, K. Sakashita, T. Higuchi, K. Takeuchi, et al. 2000. Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors. Blood 95:2821.
7. Nilsson, G., U. Miettinen, T. Ishizaka, L. K. Ashman, A. M. Irani, and L. B. Schwartz. 1994. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84:1519.
8. Sillaber, C., W. R. Sperr, H. Agis, E. Spanblöchl, K. Lechner, and P. Valent. 1994. Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4. Int. Arch. Allergy Immunol. 105:264.
9. Saito, H., M. Ebisawa, H. Tachimoto, M. Shichijo, K. Fukagawa, K. Matsumoto, Y. Iikura, T. Awaji, G. Tsujimoto, M. Yanagida, et al. 1996. Selective growth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J. Immunol. 157:343.
10. Du, Z., Y. Ll, H. Xia, A. M. Irani, and L. B. Schwartz. 1997. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells. J. Immunol. 159:838.
11. Xia, H. Z., Z. Du, S. Craig, G. Klisch, N. Noben-Trauth, J. P. Kochan, T. H. Huff, A. M. Irani, and L. B. Schwartz. 1997. Effect of recombinant human IL-4 on tryptase, chymase, and Fcε receptor type 1 expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J. Immunol. 159:2911.
12. Kirshenbaum, A. S., A. S. Worobec, T. A. Davis, J. P. Goff, T. Semere, and D. D. Metcalfe. 1998. Inhibition of human mast cell growth and differentiation by interferon γ-Ib. Exp. Hematol. 26:245.
13. Ochi, H., W. M. Hirani, Q. Yuan, D. S. Friend, K. F. Austen. and J. A. Boyce. 1999. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 190:267.
14. Godfraind, C., J. Louahed, H. Faulkner, A. Vink, G. Warnier, R. Grencis, and J. C. Renauld. 1998. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J. Immunol. 160:3989.
15. Temann, U. A., G. P. Geba, J. A. Rankin, and R. A. Flavell. 1998. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188:1307.
16. Townsend, J. M., G. P. Fallon, J. D. Matthews, P. Smith. E. H. Jolin, and N. A. McKenzie. 2000. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13:573.
17. Temann, U. A., P. Ray, and R. A. Flavell. 2002. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109:29.
18. Ihle, J. N., J. Keller, S. Oroszlan, L. E. Henderson, T. D. Copeland, F. Fitch, M. B. Prystowsky, E. Goldwasser, J. W. Schrader, E. Palaszynski, et al. 1983. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell stimulating factor activity. J. Immunol. 131:282.
19. Saito, H., K. Hatake, A. M. Dvorak. K. M. Leiferman, A. D. Donnenberg, N. Arai, K. Ishizaka, and T, Ishizaka. 1988. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc. Natl. Acad. Sci. USA 85:2288.
20. Hamaguchi, Y., Y. Kanakura, J. Fujita, S. Takeda, T. Nakano, S. Tarui, T. Honjo, and Y. Kitamura. 1987. Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. J. Exp. Med. 165:268.
21. Karimi, K., F. A. Redegeld, B. Heijdra, and F. P. Nijkamp. 1999. Stem cell factor and interleukin-4 induce thurine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Exp. Hematol. 27:654.
22. Ohashi, H., H. Morita, T. Tahara, H. Tsunakawa, A. Matsumoto, K. Ogami, A. Oda, Y. Ikeda, H. Miyazaki, and T. Kato. 1997. Inhibition of biological activity of thrombopoietin by monoclonal antibodies to human c-Mp1. Blood 90:180.
23. O'Connell, E. J., and D. C. Heilman. 1996. Asthma, In Gellis & Kogan's Current Pediatric Therapy 15. F. D. Burg, J. R. Ingelfinger, E. R. Wald, and R. A. Polin, eds. Saunders, Philadelphia, p. 708.
24. Mwamtemi, H. H., K. Koike, T. Kinoshita, S. Ito, S. Ishida, Y. Nakazawa, Y. Kurokawa, K. Shinozaki, K. Sakashita, K. Takeuchi, et al. 2001. An increase in circulating mast cell colony-forming cells in asthma. J. Immunol. 166:4672.
25. Mwamtemi, H. H., T. Higuchi, N. Sawai, E. Hidaka, and K. Koike. 2000. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow. Transplantation 69:1645.
26. Ma, F., K. Koike, T. Higuchi, T. Kinoshita, K. Takeuchi, H. H. Mwamtemi, N. Sawai, T. Kamijo, M. Shiohara, S. Horie, et al. 1998. Establishment of a GM-CSF-dependent megakaryoblastic cell line with the potential to differentiate into an eosinophilic lineage in response to retinoic acids. Br. J. Haematol. 100:427.
27. Busse, W. W., and R. F. Lemanske Jr. 2001. Asthma. N. Engl. J. Med. 344:350.
28. Stevenson, E. C., G. Turner, L. G. Heaney, B. C. Schock, R. Taylor, T. Gallagher, M. Ennis, and M. D. Shields. 1997. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin. Exp. Allergy 27:1027.
29. Ying, S., Q. Meng, A. B. Kay, and D. S. Robinson. 2002. Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin. Exp. Allergy 32:866.